MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
2.090
-0.100
-4.57%
After Hours: 2.050 -0.04 -1.91% 19:34 03/30 EDT
OPEN
2.180
PREV CLOSE
2.190
HIGH
2.236
LOW
2.060
VOLUME
653.34K
TURNOVER
--
52 WEEK HIGH
3.840
52 WEEK LOW
1.580
MARKET CAP
69.11M
P/E (TTM)
-1.5627
1D
5D
1M
3M
1Y
5Y
1D
NRx unit Hope Therapeutics partners with Emobot to deploy AI depression monitoring networkwide
Reuters · 17h ago
HOPE THERAPEUTICS, AN NRX PHARMACEUTICALS SUBSIDIARY (NASDAQ:NRXP), ANNOUNCES STRATEGIC PARTNERSHIP WITH EMOBOT TO INTEGRATE ITS AI-POWERED “DEPRESSION THERMOMETER” ACROSS ITS INTERVENTIONAL PSYCHIATRY NETWORK
Reuters · 17h ago
Weekly Report: what happened at NRXP last week (0323-0327)?
Weekly Report · 18h ago
Nrx Pharmaceuticals’ Earnings Call Signals High‑Stakes Progress
TipRanks · 3d ago
Psychedelic: Compass Pathways, NRx Pharma report earnings results
TipRanks · 4d ago
Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT)
TipRanks · 5d ago
Nrx Pharmaceuticals: Extensive Clinical, Regulatory, and Financial Risks Make Shares Highly Speculative
TipRanks · 5d ago
NRx Pharmaceuticals Stockholders Approve Incentive Plan Amendment
TipRanks · 6d ago
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.